Saturday 17 October 2026
Export OM’s income statement to Excel — free account
Outset Medical, Inc.
Outset Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $119.5 million, up 5.09% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 6.73%, free cash flow fell 90.5% and total debt rose 4.20%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
3.94
0.14
−3.43%
Follow OM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
4 | 4 | 6 | 6 |
+8 more TTM periods Free account |
| (60.09%) | (53.90%) | (106.20%) | (94.23%) | ||
| (27.97%) | (27.18%) | (30.23%) | (30.80%) | ||
ROIC |
(86.10%) | (80.83%) | (76.86%) | (74.83%) | |
Return on Tangible Assets |
(39.59%) | (36.84%) | (37.47%) | (37.65%) | |
Average Days of Receivables |
90.54 | 78.60 | 86.55 | 100.20 | |
Free Cash Flow per Share |
(2.09) | (1.86) | (3.10) | (3.03) | |
Free Cash Flow |
(38.88) | (34.25) | (47.12) | (53.91) | |
Capital Expenditures |
(0.56) | (0.74) | (0.80) | (0.62) | |
| Other line items | |||||
Cash ROIC |
(11.36%) | (9.37%) | (12.02%) | (12.94%) | |
Accounts Receivable Turnover |
3.67 | 3.78 | 3.74 | 3.57 | |
Accounts Payable Turnover |
23.26 | 53.45 | 32.94 | 24.85 | |
Inventory Turnover |
1.38 | 1.32 | 1.36 | 1.35 | |
Average Days of Payables |
23.70 | 7.53 | 2.78 | 8.41 | |
Days of Inventory on Hand |
251.73 | 259.62 | 238.96 | 240.52 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
18.25% | 18.15% | 17.77% | 20.05% | |
Selling, General and Administrative Expense of Revenue |
79.57% | 79.66% | 77.19% | 76.74% | |
Share Based Compensation of Revenue |
12.98% | 13.69% | 13.07% | 13.74% | |
Interest Coverage |
(4.81) | (4.89) | (4.78) | (4.34) | |
Operating CF/Net income |
0.52 | 0.45 | 0.57 | 0.61 | |
Depreciation/Fixed assets |
0.35 | 0.39 | 0.45 | 0.44 | |
Capex/Depreciation |
(0.43) | (0.47) | (0.38) | (0.27) | |
Revenue per Share |
6.33 | 6.40 | 7.85 | 6.75 | |
Operating CF per Share |
(2.06) | (1.82) | (3.05) | (3.00) | |
Capex per Share |
(0.03) | (0.04) | (0.05) | (0.03) | |
Capex to Sales |
0.00 | 0.01 | 0.01 | 0.01 |
Columns are period end dates